These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 26064978)

  • 21. The sympathetic nervous system and obesity: role in aetiology and treatment.
    Snitker S; Macdonald I; Ravussin E; Astrup A
    Obes Rev; 2000 May; 1(1):5-15. PubMed ID: 12119646
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sympathetic nervous system and insulin resistance: from obesity to diabetes.
    Esler M; Rumantir M; Wiesner G; Kaye D; Hastings J; Lambert G
    Am J Hypertens; 2001 Nov; 14(11 Pt 2):304S-309S. PubMed ID: 11721888
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Can the metabolic syndrome be explained by a unifying concept?
    Hjemdahl P
    Lancet Diabetes Endocrinol; 2015 Feb; 3(2):96-8. PubMed ID: 25618291
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of dietary weight loss on sympathetic activity and cardiac risk factors associated with the metabolic syndrome.
    Straznicky NE; Lambert EA; Lambert GW; Masuo K; Esler MD; Nestel PJ
    J Clin Endocrinol Metab; 2005 Nov; 90(11):5998-6005. PubMed ID: 16091482
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sympathetic overactivity and cardiovascular disease in patients with chronic obstructive pulmonary disease (COPD).
    van Gestel AJ; Kohler M; Clarenbach CF
    Discov Med; 2012 Dec; 14(79):359-68. PubMed ID: 23272688
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stress and its role in sympathetic nervous system activation in hypertension and the metabolic syndrome.
    Lambert EA; Lambert GW
    Curr Hypertens Rep; 2011 Jun; 13(3):244-8. PubMed ID: 21271362
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The sympathetic nervous system in polycystic ovary syndrome: a novel therapeutic target?
    Lansdown A; Rees DA
    Clin Endocrinol (Oxf); 2012 Dec; 77(6):791-801. PubMed ID: 22882204
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The peripheral sympathetic nervous system in human obesity.
    van Baak MA
    Obes Rev; 2001 Feb; 2(1):3-14. PubMed ID: 12119635
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autonomic dysregulation and the metabolic syndrome: pathologic partners in an emerging global pandemic.
    Lopes HF; Egan BM
    Arq Bras Cardiol; 2006 Oct; 87(4):538-47. PubMed ID: 17128327
    [No Abstract]   [Full Text] [Related]  

  • 30. Central mechanisms in sympathetic nervous dysregulation in obesity.
    Patel M; Braun J; Lambert G; Kameneva T; Keatch C; Lambert E
    J Neurophysiol; 2023 Dec; 130(6):1414-1424. PubMed ID: 37910522
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiovascular risk and adrenergic overdrive in the metabolic syndrome.
    Grassi G; Quarti-Trevano F; Seravalle G; Dell'Oro R
    Nutr Metab Cardiovasc Dis; 2007 Jul; 17(6):473-81. PubMed ID: 17451923
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heart of the matter: coronary dysfunction in metabolic syndrome.
    Berwick ZC; Dick GM; Tune JD
    J Mol Cell Cardiol; 2012 Apr; 52(4):848-56. PubMed ID: 21767548
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Depressor effect by exercise training is associated with amelioration of hyperinsulinemia and sympathetic overactivity.
    Kohno K; Matsuoka H; Takenaka K; Miyake Y; Okuda S; Nomura G; Imaizumi T
    Intern Med; 2000 Dec; 39(12):1013-9. PubMed ID: 11197783
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autonomic Regulation of Glucose Homeostasis: a Specific Role for Sympathetic Nervous System Activation.
    Carnagarin R; Matthews VB; Herat LY; Ho JK; Schlaich MP
    Curr Diab Rep; 2018 Sep; 18(11):107. PubMed ID: 30232652
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sympathetic overactivity--the Cinderella of cardiovascular risk factors in dialysis patients.
    Vonend O; Rump LC; Ritz E
    Semin Dial; 2008; 21(4):326-30. PubMed ID: 18627567
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sympathetic nerve activity in obstructive sleep apnoea.
    Narkiewicz K; Somers VK
    Acta Physiol Scand; 2003 Mar; 177(3):385-90. PubMed ID: 12609010
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Obesity-related metabolic syndrome: mechanisms of sympathetic overactivity.
    Canale MP; Manca di Villahermosa S; Martino G; Rovella V; Noce A; De Lorenzo A; Di Daniele N
    Int J Endocrinol; 2013; 2013():865965. PubMed ID: 24288531
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sympathetic nervous system function and dysfunction in chronic hemodialysis patients.
    Rubinger D; Backenroth R; Sapoznikov D
    Semin Dial; 2013; 26(3):333-43. PubMed ID: 23627490
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reliability of heart rate as neuroadrenergic marker in the metabolic syndrome.
    Quarti Trevano F; Seravalle G; Macchiarulo M; Villa P; Valena C; Dell'Oro R; Mancia G; Grassi G
    J Hypertens; 2017 Aug; 35(8):1685-1690. PubMed ID: 28350577
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of weight loss versus weight loss maintenance on sympathetic nervous system activity and metabolic syndrome components.
    Straznicky NE; Grima MT; Eikelis N; Nestel PJ; Dawood T; Schlaich MP; Chopra R; Masuo K; Esler MD; Sari CI; Lambert GW; Lambert EA
    J Clin Endocrinol Metab; 2011 Mar; 96(3):E503-8. PubMed ID: 21177786
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.